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he National Institutes of Health (NIH) Con-
sensus Development Conference noted that depression
is one of the most frequent psychiatric disorders of old
age, with a prevalence of 1% for major depression, 2%
for dysthymia, and 8% to 15% for clinically significant
depressive symptoms.
1 Over 50% of hospitalized
depressed elderly patients are in their first episode.
2
Epidemiological studies have shown that the majority
of individuals suffering from major depression or dys-
thymia have no history of previous psychiatric treat-
ment.
3
Earlier we suggested that late-onset depression is a het-
erogeneous syndrome, which, among others, encom-
passes patients with brain disorders that may or may not
be clinically evident when the depression first appears.
4
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We have suggested that cerebrovascular disease may predispose, precipitate, or perpetuate some late-life
depressive syndromes. The mechanisms of “vascular depression” include disruption of cortico-striato-pal-
lido-thalamo-cortical (CSPTC) pathways or their modulating systems. This view is supported by the pre-
sentation of vascular depression, which consists of depressive symptoms, cognitive abnormalities, as well
as neuroimaging findings that may result from CSPTC impairment. Moreover, clinical and electrophysio-
logical evidence of CSPTC impairment, an abnormality frequently found in patients with vascular depres-
sion, appears to be associated with poor response to antidepressant treatment and early relapse and recur-
rence. The vascular depression hypothesis provides the conceptual background for studies that may have
clinical and theoretical impact. Agents influencing dopamine, acetylcholine, and opioid neurotransmit-
ters may be studied in vascular depression, since these are essential neurotransmitters of the frontostri-
atal circuitry. Drugs used for prevention and treatment of cerebrovascular disease may be shown to reduce
the risk for vascular depression or improve its outcomes. The choice of antidepressants in vascular depres-
sion may depend on their effect on neurological recovery from ischemic lesions. Finally, identification of
specific relationships between specific symptoms, cognitive deficits, and disability may lead to interven-
tions that target the patients’ deficits as well as their interactions with psychosocial factors known to con-
tribute to depression. Research can clarify the pathways to vascular depression by focusing on the site of
lesion, the resultant brain dysfunction, the presentation of depression and time of onset, and the contri-
bution of nonbiological factors.
George S. ALEXOPOULOS Late-onset depressives have more cognitive
5,6 and neu-
roradiological abnormalities,
7-9 greater disability,
10 med-
ical morbidity and mortality,
11,12 and lower familial
prevalence of mood disorders than elderly early-onset
depressives,
11 although some disagreement exists.
14-16
Studies of late-onset depression are confounded by: (i)
difficulties in identification of age of onset
17;and (ii) the
assumption that depressive episodes have the same eti-
ology over time,although some patients may experience
episodes with different causes at different periods of
their lives. Nevertheless,research on late-onset depres-
sion has provided a conceptual step for identifying more
homogeneous groups of geriatric depression. Depres-
sion occurring in the context of vascular disease may
account for many geriatric depression cases with rather
homogeneous etiology.
Recently,we hypothesized that cerebrovascular disease
can predispose, precipitate, or perpetuate a depressive
syndrome in some elderly patients.We selected the term
“vascular depression”
18 because it is broad and encom-
passes depressive syndromes with diverse vascular
pathogenesis. Direct testing of the vascular depression
hypothesis is not possible since there is no biological test
that can function as a validating criterion.However,the
vascular depression hypothesis can generate studies of
the outcomes, pathogenesis, and treatment of a large
subgroup of geriatric depressives. We present below
findings relevant to the vascular depression hypothesis
and discuss their clinical and theoretical value.
Clinical studies
Depression and cerebrovascular disease often coexist.
An early longitudinal study observed that cerebrovas-
cular disease occurring 2 to 3 years prior to psychiatric
admission may have contributed to the development of
geriatric depression.
19 Post and Schulman noted a high
incidence of cerebrovascular disease in elderly
depressed patients and suggested that the resultant
brain damage predisposes to late-life depression.
20
Patients with vascular diseases often have depression.
In a sample of 15186 patients treated in a primary care
setting,we observed that those with significant depres-
sive symptomatology had a higher frequency of vascu-
la disease than nondepressed patients.Approximately
8% of depressed patients had hypertension, 9% had
ischemic heart disease, 13% had peripheral vascular
disease,7% had stroke,and 9% had heart failure.
21The
corresponding percentages for nondepressed patients
were 4%, 4%, 4%, 5%, and 4%, respectively. In a
prospectively followed population of 248 patients who
underwent coronary artery bypass,43% had significant
depressive symptomatology prior to surgery.
22 Similar
findings have been reported by others who observed
that patients with hypertension,
23 coronary artery dis-
ease,
24 and vascular dementia
25 often develop depres-
sion. Patients with vascular dementia have more retar-
dation, depression, and anxiety than Alzheimer's
patients with similar cognitive impairment.
22 Unlike
Alzheimer's disease,vascular dementia is a subcortical
dementia.Therefore, these findings raise the question
whether damage of subcortical structures by vascular
lesions contributes to depression.
Ischemic brain lesions in 
geriatric depression
In a series of elegant studies,Robinson and Starkstein
26
and other investigators
27-29 demonstrated that depression
is a frequent complication of stroke.Stroke with neuro-
logical symptoms and signs occurs in a relatively small
number of geriatric depressives. However, “silent
stroke”without neurological signs is frequent in elderly
depressed populations.In a Japanese sample,silent cere-
bral infarction was found in 83% of major depressives
older than 65 years.
30 Silent cerebral infarction was
observed in 94% of patients with onset of first depres-
sive episode after 65 years of age.While this investiga-
tion did not include normal controls, other studies sug-
gest that silent cerebral infarction occurs in 17% of
healthy individuals in their fifties and 21% of individu-
als in their sixties.
31 A study of Caucasian populations
found that silent stroke occurs in 23% of individuals
older than 65 years;in 72% of them the lesions exceeded
3 mm in diameter.
32These findings suggest that vascular
brain lesions can be found in a significant number of
elderly patients with late-onset depression.
Elderly depressives, and especially late-onset depres-
sives,have white matter hyperintensities (WMHs) more
frequently than nondepressed individuals.
33-37 WMHs
correspond to areas of arteriolar ectasia,enlargement of
perivascular spaces, and myelin pallor associated with
arteriosclerotic changes of perforating arteries.
38 In
asymptomatic individuals,WMHs were found to be asso-
ciated with extracranial carotid artery disease, reduced
cerebral blood flow, and a history of hypertension, dia-
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69betes,cardiac disease.
39 Not all WMHs are due to vascu-
lar disease. However, geriatric depressed patients with-
out cerebrovascular risk factors were found to have sim-
ilar degree of WMHs to nondepressed controls.
40 The
temporal relationship between the formation of WMHs
and development of depression has not been systemati-
cally investigated. However, in one case, depression
developed following a large increase in WMHs.
41
We used transcranial sonography to compare cerebral
blood flow velocity between elderly patients with major
depression and normal elderly controls.
42 Depressed
patients had reduced blood flow velocity in the middle,
anterior,and posterior cerebral artery (Figure 1).Blood
flow velocity was strongly correlated with overall cog-
nitive dysfunction, but the strongest correlations were
those with initiation/perseveration scores of the Mattis
Dementia Rating Scale.
43
Lesions in the basal ganglia are associated with depres-
sion.Approximately 40% to 75% of depressed elderly
patients have lesions of the thalamus and basal ganglia,
36
while only 5% of normal elderly controls have such
lesions,and their lesions are smaller than the lesions of
elderly depressives.
The clinical presentation 
of vascular depression
Vascular disease contributes to cognitive impairment.
The incidence of dementia 1 year after the first cerebral
infarct was found to be 9 times greater than expected.
44
Lacunar infarcts in the basal ganglia, thalamus, and
deep white matter,but not cortical infarcts,appear to be
associated with high prevalence of dementia in
Alzheimer's patients.
45
Declining cognitive performance,perhaps due to unrec-
ognized vascular disease, was found to be a stroke risk
factor.
46 WMHs were correlated with impaired atten-
tion, mental speed, and executive functions
47-50 in non-
depressed subjects.
Late-onset depressives with vascular risk factors were
reported to have greater cognitive impairment than
elderly patients with early-onset depression without
vascular risk factors.
18,51 Executive functions were most
affected.In vascular dementia,a subcortical syndrome
frequently associated with depression, the extent of
WMHs correlated with cognitive impairment.
52 In cor-
tical or basal ganglia stroke,cognitive impairment was
associated with high incidence and increased severity
Basic research
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Figure 1. Blood flow velocity in the middle cerebral artery in an 82-year-old patient with major depression (left) and a 79-year-old psychiatrically
normal subject (right). Blood flow velocity was measured with transcranial sonography.of depression.
26 These findings suggest that cere-
brovascular lesions lead to depression and cognitive
impairment through related mechanisms.
Patients with late-onset major depression and vascular
risk factors or ischemic brain lesions appear to have
more psychomotor retardation, apathy, and lack of
insight, and less agitation and guilt than geriatric
patients with early-onset depression without vascular
risk factors.
42,53 Moreover,patients with vascular depres-
sion have greater impairment in frontal functions and
more disability.
18 Identification of relationships among
specific symptoms,lesion location,and overall damaged
tissue can provide information about the pathogenesis
of vascular depression.
Localization of lesions
The clinical presentation of vascular depression sug-
gests that damage of subcortical structures and their
connections to some frontal lobe structures are the
contributing pathophysiological abnormality. This
view is further supported by the observation that sub-
cortical dementing disorders, including vascular
dementia, Parkinson's disease, and Huntington's dis-
ease,are more likely to result in depression than corti-
cal dementias.
54 In contrast, patients with Alzheimer's
disease develop depression less frequently and have
less severe depressive syndromes than patients with
subcortical dementias.
55 Moreover, development of
depression is more likely to occur in Alzheimer's
patients with subcortical atrophy.
56
The pathogenetic role of subcortical lesions in depres-
sion is supported by studies of stroke.Stroke of the cau-
date head is the most likely to result in depression,
while thalamic stroke has a rather low incidence of
depression.
57 Most depressed patients with silent cere-
bral infarction have lesions in the perforating arteries
territory.
30 Similarly,WMHs of elderly depressives are
most prominent in subcortical and frontal areas.
34-36
Reduced size of the head of the caudate
58 and puta-
men
59 has been observed in neurologically unimpaired
depressed patients.
Lesions of the left hemisphere often result in depres-
sion.
26 Depression may occur after right hemisphere
stroke,
60,61 despite difficulties in the recognition of
depression due to anosognosia. Depressed mood is
infrequent in right-sided stroke, but vegetative signs
and abnormal dexamethasone suppression test are
equally frequent in left and right stroke.
60 In left hemi-
sphere stroke, anterior lesions were associated with
depression more often than posterior lesions.
26A more
complex lesion-location relationship was observed in
right stroke.Immediately after right stroke,depression
was more severe in patients with posterior lesions,
62
while the severity of depression occurring within 3 to 6
months after right stroke was associated with anterior
lesions.
62,63 These observations suggest that poststroke
depression is mediated by different mechanisms,espe-
cially in patients with right hemisphere lesions.
The pathogenetic contribution of the basal ganglia and
their prefrontal connections is supported by functional
neuroimaging studies. Most functional neuroimaging
studies of major depression observed hypoactivity in
frontal regions,
64-66 including the dorsolateral, inferior
and medial/anterior cingulate, and the caudate nucle-
us,
67,68 but disagreement exists.
69
Prefrontal and limbic dysfunction in depression has
been suggested by positron emission tomography
(PET) activation studies of younger adults. Intra-
venous administration of procaine can induce emo-
tional experiences associated with increased blood
flow in the anterior temporal lobes, inferior frontal
lobes, and anterior cingulate gyri in normal subjects.
70
However, minimal activation of these regions was
noted in depressives who have the same experiences as
the normal subjects.
70
Left prefrontal areas may participate in the develop-
ment of sad mood.Transient sadness increases the
activity of the left anterolateral prefrontal cortex,
71
left anterior cingulate,left medial frontal cortex,and
left anterior limbic system.
72The relationship of these
findings to depression is unclear.However,they sug-
gest that the left prefrontal system and its connec-
tions to limbic areas mediate some aspects of depres-
sive symptomatology.
We used high-sensitivity H2
15O PET with an activation
task to probe frontotemporal function in elderly
patients with severe major depression (Hamilton
Depression Rating Scale >30) and elderly controls.
73
Each session included 4 scans during a paced word gen-
eration condition with phonemic cues, and 4 scans in a
paced letter repetition sensorimotor control state.
Group differences in brain activity were identified with
statistical parametric mapping according to the general
linear model at each voxel. Brain activity during word
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71generation (activation vs control states) was
decreased bilaterally in the dorsal anterior cingulate
(P<0.001) and the hippocampal areas in depressed
elderly patients compared to controls (Figure 2).These
findings suggest that the striatofrontal circuitry and its
connections to the hippocampus may be the neural
substrates of some of the cognitive and psychomotor
symptoms and signs of geriatric depression.
Some aspects of the depressive syndrome are asso-
ciated with rather specific functional brain abnor-
malities in younger depressives. Psychomotor slow-
ing was found to be correlated with decreased flow
in the left anterolateral cortex, while cognitive
impairment correlated with decreased activity in
the left medial prefrontal area.
74 Anxiety occurring
in the context of depression was associated with
increased activity in the right posterior cingulate
and bilateral inferior parietal areas.
75 These obser-
vations suggest that
distinctive depressive
syndromes may result
from vascular lesions
that disrupt specific
prefrontal-subcortical
circuits.
Three cortico-striato-
pallido-thalamo-corti-
cal (CSPTC) pathways
may be relevant to
depression.
76,77 Damage
of the orbitofrontal
circuit may lead to dis-
inhibition, irritability,
and diminished sensi-
tivity to social cues.
76
Damage of the anteri-
or cingulate may result
in apathy and reduced
initiative.
76 Damage of
the dorsolateral circuit
may result in difficul-
ties in set shifting,
learning, and word list
generation.
76 These
behavioral abnormali-
ties resemble in part
the depressive syn-
drome.
Treatment response
in vascular depression
Several studies suggest that vascular depression may
have a poor outcome. Late-onset depression, an entity
that often occurs in the context of vascular disease, is a
rather chronic disorder.
78 In elderly depressives,
leukoencephalopathy was found to be associated with
low quantitative electroencephalogram (qEEG) coher-
ence
79,80; low qEEG coherence predicted failure to
recover,residual depressive symptomatology,increased
mortality,and disability.
79,80
We studied the relationship of clinical, neuropsycho-
logical, and electrophysiological measures of pre-
frontal dysfunction with treatment response in elderly
patients with major depression.
81 Abnormal initia-
tion/perseveration scores of the Dementia Rating
Scale,psychomotor retardation,and long P300 latency
Basic research
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aof the auditory evoked potential predicted 58% of the
variance in change of depression scores from baseline
to 6 weeks.Depressed patients who remained sympto-
matic had more abnormal initiation/perseveration
scores and longer P300 latency compared with
depressed patients who achieved remission and control
subjects.There were no differences between the last
two groups.These findings suggest that prefrontal dys-
function is associated with poor or delayed antide-
pressant response in depressed elderly patients.
Although not very specific, abnormal initiation/perse-
veration scores, psychomotor retardation, and long
P300 latency are thought to reflect striatofrontal
impairment, an abnormality often caused by vascular
disease.
82 We are currently conducting a study of aver-
age evoked responses following the Stroop response
inhibition test. The Stroop requires integrity of the
anterior cingulate and thus is more specific to frontal
dysfunction than our earlier tests.Preliminary findings
suggest that, compared with controls,depressed elderly
patients overrecruit prefrontal neurons during the
response inhibition task (Figure 3).Further research will
examine whether this abnormality is associated with poor
reponse to antidepressants.
In another study, we investigated the relationship of exec-
utive and memory impairment to relapse, recurrence, and
the course of residual depressive symptoms and signs after
remission of geriatric major depression.
83 The subjects of
this study, after remission of depression, received continu-
ation treatment with nortriptyline at plasma levels 60 to
150 ng/mL for 16 weeks and were then randomly assigned
to either nortriptyline maintenance therapy or placebo for
a period of up to 2 years. Abnormal initiation/persevera-
tion scores, but not memory impairment, were associated
with relapse (Figure 4) and recurrence (Figure 5) of geri-
atric depression and with fluctuations of depressive symp-
tomatology in the whole
group and in subjects who
never met criteria for
relapse or recurrence
during the follow-up
period. Memory impair-
ment, disability, medical
burden, social support,
and history of previous
episodes did not signifi-
cantly influence the out-
come of depression in this
sample. These findings
provide the rationale for
studies of the role of spe-
cific prefrontal pathways
in predisposing or perpet-
uating depressive syn-
dromes or symptoms in
the elderly.Abnormal ini-
tiation/perseveration
scores reflect stri-
atofrontal dysfunction,an
abnormality associated
with vascular depression.
While direct studies are
needed, these findings
suggest that vascular
depression has a chronic
and relapsing course.
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Figure 2. Decreased activity in
bilateral hippocampi (a) and
bilateral anterior cingulate gyri
(b), in geriatric patients with
major depression vs control sub-
jects using a word generation
paradigm, as detected with high-
sensitivity H2
15O positron emis-
sion tomography (PET) activation.
Highlighted areas reflect group
differences (P<0.01) of functional
PET results superimposed on a
structural T1 weighted template.
73
bBasic research
74
Figure 3. Increased frontal activation in a 73-year-old patient with major depression (top) compared with a 70-year-old psychiatrically normal sub-
ject (bottom). Evoked responses were recorded following the Stroop Color Interference task. A total of 162 color-congruent words and 162
color-incongruent words presented for 500 milliseconds every 2 seconds in random order. Topographical maps of evoked potential activ-
ity were constructed after sorting the correct responses to the incongruent task and estimating the voltage distributions across the scalp.Mechanisms of  vascular depression
Two broad hypotheses can be tested regarding localiza-
tion of lesions in vascular depression.The first hypothe-
sis is that small lesions disrupting critical pathways may
precipitate vascular depression.This hypothesis is sup-
ported by stroke studies showing that lacunar infarcts of
the left caudate head or the left frontal pole often lead
to depression.
26 The direct lesion-depression pathway
may account for vascular depression cases that develop
after stroke.
The second hypothesis is that accumulation of lesions
exceeding a threshold predisposes to depression.This
hypothesis is most applicable to patients with neurolog-
ically silent lesions or an old stroke.The threshold con-
cept is supported by the observation that a total area of
WMHs exceeding 10 cm
2 may result in impaired atten-
tion and executive skills.
82 Similar impairments have
been noted in late-onset depression with vascular risk
factors.
84-87 Vascular lesions may damage glutaminergic
fibers from cortical areas to the striatum, or the
GABAergic neurons of the limbic-basal ganglia circuits
and alter the input to cortex.
88 Since these systems are
“redundant,” depressive symptoms may appear if the
overall damage exceeds a critical level and leads in
increased inhibitory CSPTC input.Another mechanism
may involve damage of catecholamine neurons by white
matter lesions at the pons, resulting in reduction of
stress responses.
74A third mechanism postulates disrup-
tion of control exerted by the orbitofrontal cortex on
the serotoninergic raphe nuclei.
89We have reported that
depressives with vascular risk factors have greater dys-
function in auditory transmission at the pons than geri-
atric depressives without vascular risk factors or elderly
normal controls.
90 These putative mechanisms suggest
that lesions at various sites may result in depression
through direct disruption of the CSPTC circuits or their
modulating systems.
The “threshold hypothesis” postulates vulnerability
that may be conferred by the lesions themselves or by
a broader cerebrovascular disturbance that compro-
mises pathways relevant to depression. Nonbiological
factors may be required to trigger depression in pre-
disposed patients. Depression developing 3 months
after stroke was found to be predicted by impairment
in activities of daily living, while depression occurring
12 months after stroke was predicted by social isola-
tion.
91 Other studies have shown that reverse occipital
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Figure 4. Cox proportional hazard analysis of 57 elderly patients
who had recovered from major depression and received
continuation treatment with nortriptyline at plasma levels
of 60 to150 ng/mL. Seven patients had a relapse during
continuation phase. Fitted survival curves with low (first
quartile) and high (3rd quartile) scores of the initiation/per-
severation (IP) domain of the Mattis Dementia Rating Scale
are shown.
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Figure 5. Cox proportional hazard analysis of 43 elderly patients who
had recovered from major depression, completed a 16-week
continuation treatment with nortriptyline at plasma levels
of 60-150 ng/mL and were randomly assigned to nortripty-
line (NT) or placebo (PL) maintenance treatment. Fifteen
patients had a recurrence during maintenance treatment
phase; 4 were on nortriptyline and 11 were on placebo. Fit-
ted survival curves with low (first quartile) and high (3rd
quartile) scores of the initiation/perseveration (IP) domain of
the Mattis Dementia Rating Scale are shown.asymmetry (right larger than left), absence of ven-
triculomegaly, and absence of family history of mood
disorders are associated with lower frequency of post-
stroke depression.
26 Studies of outcomes of patients
with vascular disease or risk factors can identify bio-
logical and nonbiological mechanisms that mediate or
protect against depression.
Prevention of vascular depression
The vascular depression hypothesis provides the con-
ceptual background for primary prevention of geriatric
depression by modifying risk factors for cerebrovascular
disease. Hypertension is a significant risk factor for
stroke.
92-94Treatment of hypertension
95 and hypercholes-
terolemia
96 reduces cerebrovascular morbidity and mor-
tality.Warfarin and aspirin reduce the risk of stroke in
patients with atrial fibrillation.
97Ticlopidine,
98 aspirin,
98,99
and dipyridamole
99 may prevent future stroke in patients
with transient ischemic attacks or ischemic stroke.Stud-
ies are needed to ascertain whether antihypertensive,
anticholesterolemic, and antiplatelet agents alter the
course of vascular depression.Antiplatelet agents may
prove to be effective in preventing further vascular dam-
age occurring during depressive episodes,when the sero-
tonin-mediated thrombogenic platelet response is
enhanced.
100,101 In addition, longitudinal studies of
patients with vascular depression can evaluate the effi-
cacy of these agents in improving the course of illness.
Drugs that reduce damage after stroke may be rele-
vant to vascular depression. These include throm-
bolytic agents, calcium-and sodium-channel antago-
nists, N-methyl-D-aspartate (NMDA) receptor
antagonists,glutamate synthesis inhibitors,glutamate-
release inhibitors, -aminobutyric acid (GABA) antag-
onists, gangliocides, aminosteroids, antioxidants,
growth factors,and antiapoptotic agents.
102The role of
these drugs in the prevention and treatment of vascu-
lar depression can be examined in patients with
ischemic events participating in acute intervention and
secondary prevention trials.
Treatment of vascular depression
Psychotropic drugs used in depressed elderly patients
may influence recovery from ischemic lesions.Animal
studies suggest that the dopamine receptor blocker
haloperidol,the  1-adrenergic receptor antagonists tra-
zodone and amitriptyline, the  2-adrenergic receptor
clonidine, and GABA agonists such as diazepam and
phenytoin interfere with motor recovery after ischemic
lesions.
102-104 In contrast, amphetamine, desipramine, the
dopamine agonist bromocriptine,and the  2-adrenergic
receptor antagonists yohimbine and idazoxan may be
beneficial to recovery from ischemic injury.
102-104 A clini-
cal study has observed that fluoxetine may facilitate and
maprotiline may hinder recovery in poststroke hemi-
plegic patients undergoing rehabilitation.
105 Studies may
examine which psychotropic agents influence the inci-
dence of poststroke depression or alter the course of
vascular depression. and identify antidepressants suit-
able for prophylaxis of vascular depression.
The presence of subcortical abnormalities and their
adverse impact on the treatment response and the long-
term outcome of vascular depression provide the ratio-
nale for studies of agents that influence the neurotrans-
mitter systems of frontostriatal circuitry. Further
research may determine the efficacy of drugs acting on
the dopamine,acetylcholine,and opiate systems of pre-
frontal pathways in patients with vascular depression.
We have observed a relationship between disability and
abnormal scores of initiation/perseveration and psy-
chomotor retardation,
10 abnormalities that frequently
occur in vascular depression. Disability is also associat-
ed with anxiety and depressive ideation in depressed
elderly patients.
10 Cognitive behavioral therapy com-
bined with rehabilitation approaches have been found to
reduce depression and improve quality of life.
106 Such
interventions may be useful in disabled patients with
vascular depression provided that they are individual-
ized and address the cognitive deficits of these patients.
Conclusion
Clinical and neuroimaging studies suggest that cere-
brovascular disease may predispose, initiate, or per-
petuate late-life depression,perhaps by compromising
the integrity or regulation of CSPTC systems. The
heuristic value of the vascular depression hypothesis is
that it provides the background for studies of mecha-
nisms of depression. Lesions at specific locations may
promote,have no effect,or even protect patients from
depression.The lesion burden concept may be relevant
to some cases of vascular depression. Structural and
functional imaging and electrophysiological tech-
niques can quantify specific lesions and total lesion
Basic research
76burden and study the functional changes associated
with lesions.
The clinical significance of the vascular depression con-
cept is that it can lead to new pharmacological and psy-
chosocial prevention and treatment models.Drugs used
in the prevention and treatment of cerebrovascular dis-
ease may be studied for their ability to reduce the risk
for depression in patients with vascular risk factors or
reduce chronicity,recurrence,cognitive impairment,and
disability in vascular depression.The long-term efficacy
of specific antidepressants can be investigated in
depressed patients at risk for new vascular lesions,since
basic research suggests that some antidepressants, and
not others,promote recovery after ischemic brain lesions.
Finally, the efficacy of agents influencing dopamine,
acetylcholine,and opioid neurotransmitters may be stud-
ied in vascular depression,since these neurotransmitters
mediate the function of the CSPTC pathways,which are
often compromised in vascular depression.
Studies of affective symptoms and cognitive deficits and
their relationship to short-term and long-term outcomes
of vascular depression can identify pathophysiological-
ly meaningful abnormalities.Linking a cognitive abnor-
mality to a specific outcome of depression suggests that
this abnormality is relevant to the mechanisms of the
depressive disorder. Since some cognitive dysfunctions
have known functional imaging correlates,it may prove
feasible to use simple-to-administer neuropsychological
tests and identify the role of specific functional abnor-
malities on the course of vascular depression. Finally,
identification of specific relationships between symp-
toms, cognitive deficits, and disability may lead to
sharply focused interventions that take into considera-
tion the interaction of the patients' deficits with psy-
chosocial factors that contribute to depression.❏
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Depresion vascular : una nueva perspectiva de la depresion de comienzo tardio
Llemos sugerido que la enfermedad cerebrovascular puede predisponer,precipitar o perpetuar algunos síndromes
depresivos que aparecen en la edad avanzada.Los mecanismos de la “depresión vascular”incluyen la interrupción
de las vías córtico-estriato-pálido-tálamo-corticales (CEPTC) o de sus sistemas de modulación.Esta perspectiva se
ve apoyada por el modo en que se manifiesta la depresión vascular,la cual consiste en síntomas depresivos,anom-
alías cognoscitivas, y constataciones específicas en neuroimágenes, que parecen resultar del deterioro de las vías
CEPTC. Además, se asocia a las pruebas clínicas y electrofisiológicas del deterioro de estas vías, lo cual es una
anomalía frecuentement observada en pacientes con depresión vascular, una respuesta insuficiente al tratamiento
antidepresivo y una pronta recaída y recidiva.La hipótesis de la depresión vascular aporta un sustrato conceptual
para estudios que podrían tener un importante impacto clínico y teórico. Deberían estudiarse los fármacos que
influyen en los neurotransmisores dopaminérgicos,acetilcolinérgicos y opiáceos en la depresión vascular,ya que se
trata de neurotransmisores esenciales del circuito frontoestriatal. Los fármacos utilizados en la prevención y
tratamiento de la enfermedad cerebrovascular parecen ser eficaces para reducir el riesgo de depresión vascular o
para mejorar sus consecuencias.La elección delos antidepresivos para tratar la depresión vascular depende de sus
efectos sobre la recuperación neurológica de las lesiones isquémicas.Finalmente,la identificación de las relaciones
específicas entre los síntomas específicos,los déficits cognoscitivos y la consiguiente incapacidad puede conducir a
intervenciones dirigidas a los déficits de los pacientes y sus interacciones con factores psicosciales que, como es
sabido, contribuyen a la depresión. La investigación puede esclarecer las causas de la depresión vascular, concen-
trándose en el sitio de la lesión, en la disfunción cerebral resultante, en la manifestación de la depresión en su
momento de aparición y en la contribución de los factores no biológicos.REFERENCES
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La dépression vasculaire : une nouvelle approche de la dépression du sujet âgé
Nous avons suggéré que les maladies cérébrovasculaires favorisent, accélèrent ou perpétuent certains syndromes
dépressifs du sujet âgé.Les mécanismes de la “ dépression vasculaire ”incluent une interruption des voies cortico-
striato-pallido-thalamo-corticales (CSPTC) ou de leurs systèmes régulateurs. Ce point de vue est étayé par le
tableau de cette forme de dépression qui combine des symptômes dépressifs, des troubles cognitifs et des données
obtenues en imagerie cérébrale,lesquelles résulteraient des altérations des voies CSPTC.En outre,les altérations cli-
niques et électrophysiologiques reflétant un dysfonctionnement des voies CSPTC sont fréquemment retrouvées
chez les patients souffrant de dépression vasculaire et sont associées à une réponse pauvre aux traitements antidé-
presseurs, à des rechutes précoces et à des récidives. L’hypothèse de la dépression vasculaire constitue une base 
conceptuelle pour des études qui peuvent avoir un impact clinique et théorique.Les agents qui influent sur certains
neurotransmetteurs comme la dopamine, l’acétylcholine et les opioïdes peuvent être étudiés dans cette dépression,
car ceux-ci jouent un rôle essentiel dans le circuit frontostriatal. Les médicaments utilisés dans la prévention et le
traitement des maladies cérébrovasculaires pourraient avoir un effet démontré sur le risque de dépression vasculaire
ou améliorer son pronostic. Le choix d’antidépresseurs adaptés à ce syndrome peut dépendre de leur effet sur la
récupération neurologique qui succède aux lésions de nature ischémique.Au bout du compte,la mise en évidence de
relations spécifiques entre les symptômes caractéristiques,les troubles cognitifs et le handicap pourrait déboucher sur
des interventions visant à la fois les déficits et leurs interactions avec les facteurs psychosociaux qui contribuent à la
dépression.La recherche peut clarifier les voies impliquées dans la dépression vasculaire en se focalisant sur le site
des lésions, le dysfonctionnement cérébral qui en résulte et la présentation de la dépression au moment où elle
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